SCHEMBL6428912

SCHEMBL6428912

O=C1CC(CO)(SCc2ccccc2)CO1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.33
CRBN Q96SW2 2/20 0.32
DDB1 Q16531 1/20 0.32
ELANE P08246 1/20 0.32
LMNA P02545 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
TSHR P16473 1/20 0.31
GFER P55789 1/20 0.31
IDO1 P14902 3/20 0.31
ALDH1A1 P00352 1/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23341266 0.76 IDO1 (0.39) DAOCYP2C19TSHRIDO1ALDH1A1
SCHEMBL7310502 0.63 CYP2C19 (0.42) LMNACYP2C19ALDH1A1
SCHEMBL567897 0.62 IDO1 (0.34) CRBNDDB1ELANELMNAMAPT
SCHEMBL566958 0.62 IDO1 (0.34) CRBNDDB1ELANELMNAMAPT
SCHEMBL23341293 0.62 TP53 (0.39) ELANETSHRIDO1ALDH1A1NOS3
SCHEMBL23145532 0.62 TRPA1 (0.39) CRBNCYP2C19TSHRIDO1ALDH1A1
SCHEMBL1983726 0.62 CYP2C19 (0.41) CYP2C19TSHRALDH1A1
SCHEMBL5674135 0.60 CYP2C19 (0.39) CYP2C19TSHRALDH1A1
SCHEMBL29093049 0.59 IDO1 (0.41) LMNACYP2C19MAPTIDO1ALDH1A1
SCHEMBL2654367 0.59 ALDH1A1 (0.36) CYP2C19IDO1ALDH1A1NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1126838-A4 NITROSATED AND NITROSYLATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2005-02-16 EP disclosed
US-20030207919-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NICOX S.A. (FR) 2003-11-06 US disclosed
US-6593347-B2 Especially a nitrosated and/or nitrosylated arylpropionic acid, arylacetic acid, enolic anilide or an oxicam NITROMED, INC. 2003-07-15 US disclosed
US-20020016322-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use NICOX S.A. (FR) 2002-02-07 US disclosed
US-6297260-B1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NITROMED, INC. 2001-10-02 US disclosed
EP-1126838-A1 NITROSATED AND NITROSYLATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2001-08-29 EP disclosed
WO-2000025776-A1 NITROSATED AND NITROSYLATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2000-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016322-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use NOS2, NOS3, NOS1 DAO 1511/4885CRBN 2989/4885DDB1 1000/4885
US-20030207919-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NOS2, NOS1, NOS3 DAO 702/4885CRBN 3777/4885DDB1 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.